查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1825973

2025年產前檢測與新生兒篩檢全球市場報告

Prenatal Testing & Newborn Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，產前檢測和新生兒篩檢市場規模迅速擴張，從2024年的62.4億美元成長到2025年的69.8億美元，複合年成長率達11.8%。過去的成長得益於基因檢測技術的進步、母親年齡的成長、相關意識和教育的提升以及醫療保健政策法規的完善。

預計未來幾年產前檢測和新生兒篩檢市場規模將快速成長，到2029年將達到109.9億美元，年複合成長率（CAGR）為12.0%。預測期內的成長歸因於遺傳諮詢、技術進步、就地檢驗、遠端醫療和遠端監控。預測期內的主要趨勢包括非侵入性產前檢測 (NIPT)、胚胎著床前基因檢測 (PGT)、遠端醫療諮詢、母體血液檢測、血紅蛋白疾病和鐮狀細胞篩檢。

產前檢查和新生兒篩檢是用於評估妊娠期間胎兒和出生後新生兒健康狀況的醫療程序。產前檢查包括各種評估，例如血液檢查和超音波，以識別胎兒潛在的遺傳和發育障礙。新生兒篩檢是在出生後不久進行的檢測，以檢測代謝、遺傳和內分泌疾病，以便早期療育和治療，從而改善嬰兒的健康狀況。

產前檢測和新生兒篩檢的主要診斷類別包括非侵入性方法和侵入性方法。侵入性診斷測試涉及穿透皮膚或身體的程序，包括血液檢查、切片檢查和結腸鏡檢查等技術。這些診斷方法利用各種技術，例如篩檢和診斷技術，並應用於包括醫院和診斷中心在內的各個領域。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響，尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，新生兒篩檢新生兒篩檢新生兒篩檢的市場統計數據，包括全球市場規模、區域佔有率、競爭對手的新生兒篩檢新生兒篩檢。本產前檢測和新生兒篩檢市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全面觀點。

未來五年12.0%的成長率預測比我們先前的預測略有下降，下降了0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國醫療保健體系，因為這會增加從日本和英國進口的串聯式質譜質譜儀和代謝紊亂檢測試劑的成本，從而可能延誤早期療育，並增加新生兒加護病房的壓力。此外，關稅的影響也將透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，更為廣泛地顯現。

產前檢測和新生兒篩檢市場的成長很大程度上是由嬰兒遺傳疾病的高發性所驅動的。世界衛生組織已經確定了幾種遺傳疾病，包括地中海貧血、鐮狀細胞性貧血、血友病、囊腫纖維化、戴-薩克斯病、X染色體脆折症候群和亨廷頓氏病。鐮狀性貧血在非洲、美國、古巴、中美洲、沙烏地阿拉伯和印度血統的人群中特別常見。例如，2023 年 2 月，美國研究機構雷迪兒童基因組醫學實驗室報告稱，雷迪兒童醫院進行的一項研究發現，41% 的嬰兒死亡是由於單元點（孟德爾）遺傳疾病造成的。嬰兒遺傳疾病盛行率的上升正在推動對產前檢測和新生兒篩檢的需求。

隨著出生率的上升，產前檢測和新生兒篩檢市場有望迎來成長。產前檢測評估胎兒出生前的健康狀況，而新生兒篩檢則可在出生後立即發現某些疾病，以便在必要時進行早期療育。例如，美國政府機構疾病管制與預防中心 (CDC) 於 2024 年 4 月發布的報告顯示，2023 年剖腹產率將連續第四年上升，達到 32.4%。此外，低風險剖腹產率也將上升至 26.6%。因此，出生率的上升是產前檢測和新生兒篩檢市場的主要驅動力。

產前檢測和新生兒篩檢市場的主要企業正致力於實施創新項目，利用快速全基因組定序 (rWGS) 技術快速且準確地檢測新生兒的遺傳疾病，從而實現早期診斷和干涉，改善健康狀況。與針對特定基因或區域的傳統基因檢測方法不同，rWGS 可以捕獲人體基因組中的所有 DNA，以識別與疾病和病症相關的基因突變。例如，2022 年 6 月，美國雷迪兒童基因組醫學研究所啟動了 BeginNGS 項目，這是一項旨在在症狀出現之前識別和診斷約 400 種已知治療方法的遺傳疾病的創新項目。 BeginNGS 計劃最佳化其基因組序列測定流程，並將其檢測能力擴展到約 1000 種疾病。最終目標是每年篩檢370 萬名新生兒，並使該實踐成為全國醫院的標準程序。

產前檢測和新生兒篩檢市場的主要參與企業致力於開發創新的新生兒篩檢設備，以增強遺傳、代謝和其他健康狀況的早期檢測，從而實現及時干預並改善新生兒健康狀況。新生兒篩檢即時檢測 (POC) 設備旨在為新生兒提供更快、更便捷、更具成本效益的篩檢，並與全球使用的七種標準新生兒篩檢測試相容。例如，2023 年 9 月，總部位於印度的 Mylab Discovery Solutions Pvt. Ltd. 推出了新生兒篩檢(POC) 設備 MyNeoShield。 MyNeoShield 的設計概念是價格實惠，其成本約為現有解決方案的五分之一。透過直接向醫療保健提供者提供檢測，MyNeoShield 旨在改善關鍵醫療服務的可近性，尤其是服務不足地區的新生兒。

2022年1月，分子診斷公司Exact Sciences Corp.以1.9億美元收購了Prevention Genetics。此次收購增強了Exact Sciences先進的癌症診斷產品組合，並使其進入遺傳性癌症檢測(HCT)市場。 Prevention Genetics是一家專門從事產前和新生兒篩檢臨床DNA（基因）檢測的公司，它將補充Exact Sciences的能力並擴大其市場影響力。

產前檢測和新生兒篩檢市場的主要參與企業包括 PerkinElmer Inc.、Laboratory Corporation of America Holdings (LabCorp)、Natera Inc.、Invitae Corporation、Centogene AG、Cradle Genomics Inc.、Roche Diagnostics International AG、Quest Diagnostics Incorporated、Baebies Inc.、Progenfinity Inc.、Randm. Scientific、Illumina Inc.、Agilent Technologies Inc.、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd.、Bio-Rad Laboratories Inc.、通用電氣公司、西門子醫療股份公司、華大基因集團、QIAGEN NV、Veracyte Inc.、NIPD Genetics、Novacyt CompanyA. Diagnostics、Sonic Healthcare Limited、Cepheid a Danaher Company、Guardian Healthcare. Inc. 和泛生子健康（北京）有限公司。

2024年，產前檢測和新生兒篩檢市場最大的地區是北美。西歐是產前檢測和新生兒篩檢市場的第二大地區。產前檢測和新生兒篩檢市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

產前檢測和新生兒篩檢市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙、加拿大

產前檢測和新生兒篩檢市場涵蓋提供血液檢測服務、聽力檢測服務、CCHD篩檢檢測和非侵入性檢測的營業單位的收益。市場規模包括服務提供者銷售或包含在其服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球產前檢測與新生兒篩檢：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球產前檢測與新生兒篩檢市場：成長率分析
  • 全球產前檢測與新生兒篩檢市場表現：規模與成長，2019-2024
  • 全球產前檢測與新生兒篩檢市場預測：規模與成長，2024-2029年，2034年
  • 全球產前檢測與新生兒篩檢：總目標市場（TAM）

第6章 市場細分

  • 全球產前檢測和新生兒篩檢市場（按診斷類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 非侵入性
  • 侵入性
  • 全球產前檢測和新生兒篩檢市場（按技術、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 篩檢技術
  • 診斷技術
  • 全球產前檢測和新生兒篩檢市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷中心
  • 全球產前檢測與新生兒篩檢市場：非侵入性細分市場、類型、績效及預測（2019-2024 年、2024-2029 年、2034 年）
  • 血液檢測（遊離細胞DNA檢測）
  • 超音波
  • 母體血清篩檢
  • 全球產前檢測與新生兒篩檢市場：侵入性細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 羊膜穿刺術
  • 絨毛膜絨毛採樣（CVS）
  • 臍帶穿刺術

第7章 區域和國家分析

  • 全球產前檢測與新生兒篩檢市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球產前檢測與新生兒篩檢市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 產前檢測與新生兒篩檢市場：競爭格局
  • 產前檢測與新生兒篩檢市場：公司簡介
    • PerkinElmer Inc.
    • Laboratory Corporation of America Holdings（LabCorp）
    • Natera Inc.
    • Invitae Corporation
    • Centogene AG

第31章：其他領先和創新企業

  • Cradle Genomics Inc.
  • Roche Diagnostics International AG
  • Quest Diagnostics Incorporated
  • Baebies Inc.
  • Progenity Inc.
  • Ravgen Inc.
  • Strand Life Sciences Pvt. Ltd.
  • Eurofins Scientific
  • Illumina Inc.
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories Inc.
  • General Electric Company
  • Siemens Healthineers AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年產前檢測與新生兒篩檢市場：提供新機會的國家
  • 2029年產前檢測與新生兒篩檢市場：細分領域帶來新機會
  • 2029年產前檢測與新生兒篩檢市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r32735u

Prenatal testing and newborn screening are medical practices designed to evaluate the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing encompasses a range of assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, enabling early intervention and treatment to enhance health outcomes for infants.

The primary diagnostic categories within prenatal testing and newborn screening encompass non-invasive and invasive methods. Invasive diagnostic testing involves procedures that penetrate the skin or body, including techniques such as blood testing, biopsies, and colonoscopies. These diagnostic methods leverage various technologies, including screening and diagnostic technology, and are applied across a range of sectors, including hospitals and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The prenatal testing & newborn screening market research report is one of a series of new reports from The Business Research Company that provides prenatal testing & newborn screening market statistics, including prenatal testing & newborn screening industry global market size, regional shares, competitors with prenatal testing & newborn screening market share, detailed prenatal testing & newborn screening market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal testing and newborn screening tests industry. This prenatal testing and newborn screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal testing & newborn screening market size has grown rapidly in recent years. It will grow from $6.24 billion in 2024 to $6.98 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to advancements in genetic testing, increased maternal age, awareness and education, healthcare policy and regulations.

The prenatal testing & newborn screening market size is expected to see rapid growth in the next few years. It will grow to $10.99 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to genetic counseling, technological advancements, point-of-care testing, telehealth and remote monitoring. Major trends in the forecast period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies and sickle cell screening.

The forecast of 12.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. healthcare systems by increasing costs for tandem mass spectrometry equipment and metabolic disorder assays imported from Japan and the UK, potentially delaying early interventions and raising neonatal Intensive Care Unit burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the prenatal testing and newborn screening market is significantly driven by the high prevalence of genetic diseases in infants. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease. Among these, Sickle Cell Anemia, which predominantly affects individuals with African, American, Cuban, Central American, Saudi Arabian, and Indian ancestry, is particularly widespread. For instance, in February 2023, the Rady Children's Institute for Genomic Medicine, a U.S.-based research institute, reported that a study conducted at Rady Children's Hospital found that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This heightened prevalence of genetic diseases in infants has driven the demand for prenatal testing and newborn screening.

The prenatal testing and newborn screening market is poised for growth due to an increase in birth rates. Prenatal testing assesses the health of fetuses before birth, while newborn screening detects specific medical conditions shortly after birth, enabling early intervention when necessary. For example, in April 2024, a report published by the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, revealed that the cesarean delivery rate increased for the fourth consecutive year in 2023, reaching 32.4%. Additionally, the rate of low-risk cesarean deliveries rose to 26.6%. Therefore, the rising birth rate is a key driver of the prenatal testing and newborn screening market.

Leading companies in the prenatal testing and newborn screening market are focusing on introducing innovative programs that leverage rapid Whole Genome Sequencing (rWGS) technology to quickly and accurately detect genetic disorders in newborns, allowing for early diagnosis and intervention to improve health outcomes. rWGS technology is an advanced genomic technique that rapidly sequences an individual's entire genome. Unlike traditional genetic testing methods that target specific genes or regions, rWGS captures all the DNA in a person's genome to identify genetic variants associated with diseases or disorders. For example, in June 2022, Rady Children's Institute for Genomic Medicine, a U.S.-based organization, launched BeginNGS, a novel program aimed at identifying and diagnosing approximately 400 genetic disorders with known treatment options before symptoms appear. BeginNGS is optimizing genomic sequencing processes and plans to expand testing capabilities to include around 1,000 disorders. The ultimate goal is to screen 3.7 million newborns annually, making this practice a standard procedure in hospitals nationwide.

Key players in the prenatal testing and newborn screening market are focused on developing innovative newborn screening devices to enhance the early detection of genetic, metabolic, and other health conditions, enabling timely interventions and improved health outcomes for newborns. Newborn screening point-of-care devices are designed to provide faster, more accessible, and cost-effective screening for newborns, accommodating the seven standard newborn screening tests conducted globally. For example, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is designed to be low-cost, priced at about one-fifth of existing solutions, which typically range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to improve access to critical health services for newborns, particularly in underserved regions.

In January 2022, Exact Sciences Corp., a molecular diagnostics company, completed the acquisition of Prevention Genetics for $190 million. This acquisition enhances Exact Sciences' advanced cancer diagnostics portfolio and allows the company to enter the hereditary cancer testing (HCT) market. Prevention Genetics, a company specializing in clinical DNA (genetic) tests for prenatal testing and newborn screening, complements Exact Sciences' capabilities and expands its market presence.

Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal testing & newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The prenatal testing & newborn screening market includes revenues earned by entities by providing blood test services, hearing test services, CCHD screening tests, and non-invasive tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal Testing & Newborn Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal testing & newborn screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal testing & newborn screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prenatal testing & newborn screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Type: Non-Invasive; Invasive
  • 2) By Technology: Screening Technology; Diagnostic Technology
  • 3) By End user: Hospitals; Diagnostic centers
  • Subsegments:
  • 1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening
  • 2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis
  • Companies Mentioned: PerkinElmer Inc.; Laboratory Corporation of America Holdings (LabCorp); Natera Inc.; Invitae Corporation; Centogene AG; Cradle Genomics Inc.; Roche Diagnostics International AG; Quest Diagnostics Incorporated; Baebies Inc.; Progenity Inc.; Ravgen Inc.; Strand Life Sciences Pvt. Ltd.; Eurofins Scientific; Illumina Inc.; Agilent Technologies Inc.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Bio-Rad Laboratories Inc.; General Electric Company; Siemens Healthineers AG; BGI Group; QIAGEN N.V.; Veracyte Inc.; NIPD Genetics; Novacyt UK; Ariosa Diagnostics Inc.; Verinata Health Inc.; Counsyl a Myriad Company; GenPath Diagnostics; Sonic Healthcare Limited; Cepheid a Danaher Company; Guardant Health Inc.; Genetron Health (Beijing) Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal Testing & Newborn Screening Market Characteristics

3. Prenatal Testing & Newborn Screening Market Trends And Strategies

4. Prenatal Testing & Newborn Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prenatal Testing & Newborn Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Prenatal Testing & Newborn Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Prenatal Testing & Newborn Screening Market Growth Rate Analysis
  • 5.4. Global Prenatal Testing & Newborn Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Prenatal Testing & Newborn Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Prenatal Testing & Newborn Screening Total Addressable Market (TAM)

6. Prenatal Testing & Newborn Screening Market Segmentation

  • 6.1. Global Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive
  • Invasive
  • 6.2. Global Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening Technology
  • Diagnostic Technology
  • 6.3. Global Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic centers
  • 6.4. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Non-Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Tests (C ell-Free DNA Testing)
  • Ultrasound
  • Maternal Serum Screening
  • 6.5. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amniocentesis
  • Chorionic Villus Sampling (CVS)
  • Cordocentesis

7. Prenatal Testing & Newborn Screening Market Regional And Country Analysis

  • 7.1. Global Prenatal Testing & Newborn Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Prenatal Testing & Newborn Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal Testing & Newborn Screening Market

  • 8.1. Asia-Pacific Prenatal Testing & Newborn Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal Testing & Newborn Screening Market

  • 9.1. China Prenatal Testing & Newborn Screening Market Overview
  • 9.2. China Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal Testing & Newborn Screening Market

  • 10.1. India Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal Testing & Newborn Screening Market

  • 11.1. Japan Prenatal Testing & Newborn Screening Market Overview
  • 11.2. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal Testing & Newborn Screening Market

  • 12.1. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal Testing & Newborn Screening Market

  • 13.1. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal Testing & Newborn Screening Market

  • 14.1. South Korea Prenatal Testing & Newborn Screening Market Overview
  • 14.2. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal Testing & Newborn Screening Market

  • 15.1. Western Europe Prenatal Testing & Newborn Screening Market Overview
  • 15.2. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal Testing & Newborn Screening Market

  • 16.1. UK Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal Testing & Newborn Screening Market

  • 17.1. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal Testing & Newborn Screening Market

  • 18.1. France Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal Testing & Newborn Screening Market

  • 19.1. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal Testing & Newborn Screening Market

  • 20.1. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal Testing & Newborn Screening Market

  • 21.1. Eastern Europe Prenatal Testing & Newborn Screening Market Overview
  • 21.2. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal Testing & Newborn Screening Market

  • 22.1. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal Testing & Newborn Screening Market

  • 23.1. North America Prenatal Testing & Newborn Screening Market Overview
  • 23.2. North America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal Testing & Newborn Screening Market

  • 24.1. USA Prenatal Testing & Newborn Screening Market Overview
  • 24.2. USA Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal Testing & Newborn Screening Market

  • 25.1. Canada Prenatal Testing & Newborn Screening Market Overview
  • 25.2. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal Testing & Newborn Screening Market

  • 26.1. South America Prenatal Testing & Newborn Screening Market Overview
  • 26.2. South America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal Testing & Newborn Screening Market

  • 27.1. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal Testing & Newborn Screening Market

  • 28.1. Middle East Prenatal Testing & Newborn Screening Market Overview
  • 28.2. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal Testing & Newborn Screening Market

  • 29.1. Africa Prenatal Testing & Newborn Screening Market Overview
  • 29.2. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal Testing & Newborn Screening Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal Testing & Newborn Screening Market Competitive Landscape
  • 30.2. Prenatal Testing & Newborn Screening Market Company Profiles
    • 30.2.1. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Centogene AG Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal Testing & Newborn Screening Market Other Major And Innovative Companies

  • 31.1. Cradle Genomics Inc.
  • 31.2. Roche Diagnostics International AG
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Baebies Inc.
  • 31.5. Progenity Inc.
  • 31.6. Ravgen Inc.
  • 31.7. Strand Life Sciences Pvt. Ltd.
  • 31.8. Eurofins Scientific
  • 31.9. Illumina Inc.
  • 31.10. Agilent Technologies Inc.
  • 31.11. Thermo Fisher Scientific Inc.
  • 31.12. F. Hoffmann-La Roche Ltd.
  • 31.13. Bio-Rad Laboratories Inc.
  • 31.14. General Electric Company
  • 31.15. Siemens Healthineers AG

32. Global Prenatal Testing & Newborn Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal Testing & Newborn Screening Market

34. Recent Developments In The Prenatal Testing & Newborn Screening Market

35. Prenatal Testing & Newborn Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Prenatal Testing & Newborn Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Prenatal Testing & Newborn Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Prenatal Testing & Newborn Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer